NCT00767273View on ClinicalTrials.gov

Investigate Role of Metabolic Imaging in Predicting Tumor Response/Outcome After Pancreatic CA Tx

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Pancreatic Cancer
Interventions
PROCEDURE

PET Scan

DRUG

FLT

DRUG

FDG

Trial Locations (1)

94305

Stanford University School of Medicine, Stanford

All Listed Sponsors
lead

Stanford University

OTHER

NCT00767273 - Investigate Role of Metabolic Imaging in Predicting Tumor Response/Outcome After Pancreatic CA Tx | Biotech Hunter | Biotech Hunter